|1.||Ley, James J: 5 articles (01/2008 - 06/2002)|
|2.||Ginsberg, Myron D: 5 articles (01/2008 - 06/2002)|
|3.||Becker, David A: 5 articles (01/2008 - 06/2002)|
|4.||Belayev, Ludmila: 4 articles (11/2007 - 06/2002)|
|5.||Busto, Raul: 3 articles (06/2005 - 06/2002)|
|6.||Khoutorova, Larissa: 2 articles (06/2005 - 09/2003)|
|7.||Zhao, Weizhao: 2 articles (06/2005 - 09/2003)|
|8.||Wei, Jian Qin: 1 article (01/2008)|
|9.||Prado, Ricardo: 1 article (01/2008)|
|10.||Bishopric, Nanette H: 1 article (01/2008)|
|2.||Brain Injuries (Brain Injury)
|3.||Ganglion Cysts (Ganglion)
01/01/1999 - "The results of the combined treatments suggest that azulenyl nitrone and alpha-phenyl-N-tert-butyl nitrone do not have the same chemical effects within the ganglion cells. "
01/01/1999 - "In the present study, we show that various antioxidants, including the new spin trap azulenyl nitrone and 1,3-dimethyl-2-thiourea, protect axotomized ganglion cells, confirming that neuronal death involves an imbalance of the cellular redox status towards oxidation. "
|4.||Brain Ischemia (Cerebral Ischemia)
11/14/2007 - "Neuroprotective effect of STAZN, a novel azulenyl nitrone antioxidant, in focal cerebral ischemia in rats: dose-response and therapeutic window."
01/15/2008 - "STAZN, a second-generation azulenyl nitrone with potent neuroprotective efficacy in brain ischemia, is also a rapidly acting and highly effective cardioprotective agent in acute coronary ischemia. "
11/01/2007 - "Stilbazulenyl nitrone (STAZN) is a novel second-generation azulenyl nitrone that has been shown to have potent antioxidant properties in a rat model of brain ischemia. "
06/01/2005 - "Stilbazulenyl nitrone, a second-generation azulenyl nitrone antioxidant, confers enduring neuroprotection in experimental focal cerebral ischemia in the rat: neurobehavior, histopathology, and pharmacokinetics."
06/01/2005 - "Stilbazulenyl nitrone (STAZN) is a potent lipophilic second-generation azulenyl nitrone antioxidant, which is highly neuroprotective in rodent models of cerebral ischemia and trauma. "